Publication Date:
1992-08-21
Description:
In the last several years, the frequency and spectrum of antimicrobial-resistant infections have increased in both the hospital and the community. Certain infections that are essentially untreatable have begun to occur as epidemics both in the developing world and in institutional settings in the United States. The increasing frequency of drug resistance has been attributed to combinations of microbial characteristics, selective pressures of antimicrobial use, and societal and technologic changes that enhance the transmission of drug-resistant organisms. Antimicrobial resistance is resulting in increased morbidity, mortality, and health-care costs. Prevention and control of these infections will require new antimicrobial agents, prudent use of existing agents, new vaccines, and enhanced public health efforts to reduce transmission.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Cohen, M L -- New York, N.Y. -- Science. 1992 Aug 21;257(5073):1050-5.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, GA 30333.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/1509255" target="_blank"〉PubMed〈/a〉
Keywords:
Bacterial Infections/*drug therapy/epidemiology/prevention & control/transmission
;
Cross Infection
;
*Drug Resistance, Microbial
;
Humans
;
Risk Factors
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink